Journal Wrap | COORDINATE-Diabetes Improves Evidence-Based Care; AFib Associated With Higher Mortality in Patients With CIEDs
The hottest research from various peer-reviewed journals – handpicked weekly by the ACC.org Editorial Board led by Kim A. Eagle, MD, MACC.
COORDINATE-Diabetes Intervention Improves Evidence-Based Care Across Sex, Race and Ethnicity
A multifaceted, clinic-based intervention shown to increase the use of evidence-based medications in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD) in the COORDINATE-Diabetes trial was found to provide an equitable improvement regardless of sex, race or ethnicity, according to a prespecified secondary analysis published in Circulation.
AFib Associated With Higher Mortality in Patients With CIEDs
Device-recognized atrial fibrillation (AFib) may be associated with a higher risk of all-cause mortality in patients with cardiac implantable electronic devices (CIEDs), according to a study published in Circulation.
Clinical Topics: Arrhythmias and Clinical EP, Diabetes and Cardiometabolic Disease, Heart Failure and Cardiomyopathies, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Atrial Fibrillation/Supraventricular Arrhythmias, Acute Heart Failure, Pulmonary Hypertension, Hypertension
Keywords: Cardiology Magazine, ACC Publications, Ethnic Groups, Gender Equity, Critical Pathways, Comorbidity, Atrial Fibrillation, Heart Failure, Hypertension, Hypertension, Pulmonary, Coronary Vessels
